
Sign up to save your podcasts
Or
This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421
4.3
3030 ratings
This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421
129 Listeners
313 Listeners
160 Listeners
853 Listeners
488 Listeners
264 Listeners
89 Listeners
133 Listeners
1,071 Listeners
53 Listeners
169 Listeners
506 Listeners
317 Listeners
244 Listeners
409 Listeners